United Kingdom Cyberknife Market Size, Share, and COVID-19 Impact Analysis, By Application (Oncology, Neurology, Pain Management, Pediatrics), By Procedure Type (Stereotactic Radiosurgery, Stereotactic Body Radiation Therapy, Fractionated Stereotactic Radiation Therapy), and United Kingdom Cyberknife Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Cyberknife Market Insights Forecasts to 2035

• The United Kingdom Cyberknife Market Size was Estimated at USD 16.66 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 17.54% from 2025 to 2035
• The United Kingdom Cyberknife Market Size is Expected to Reach USD 98.56 Million by 2035

According to a research report published by Spherical Insights and Consulting, the United Kingdom Cyberknife Market Size is anticipated to reach USD 98.56 Million by 2035, Growing at a CAGR of 17.54% from 2025 to 2035. The industry's growth is being driven by the rising incidence of chronic diseases, novel product introductions, and the growing preference for minimally invasive or non-invasive therapies over surgery.

Market Overview

The United Kingdom cyberknife market refers to the industry focused on the production and application of the cyberknife is a stereotactic radiosurgery system (SRS). They are equipped with a cutting-edge radiosurgery technique that employs a robotic arm to administer high doses of focused radiation to eliminate lesions or tumors, guaranteeing non-invasive, painless therapy. When compared to proton radiation treatment, Cyberknife is the most advanced technology and offers many advantages. Tumors in the prostate, brain, spine, head, lung, neck, liver, kidney, and pancreas are the primary locations treated by this method. Additionally, it is regarded as a radiosurgery tool that does not require a frame to target. It is sometimes referred to as the synchrony system or synchrony method, and it combines light-emitting optical fibers installed on the patient's body with surgically placed internal fiducials. An infrared tracking camera tracks the optical fibers. Patients who have already received high amounts of radiation therapy can benefit from Cyberknife radiosurgery.

Report Coverage

This research report categorizes the market for the United Kingdom cyberknife market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom cyberknife market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom cyberknife market.

Driving Factors

The market for the United Kingdom cyberknife is influenced by the country's rapid growth in healthcare and the significant investments made by top automakers in next-generation technologies.  Government agencies take steps to further develop the market. In addition, a number of other market participants are making significant investments in the industry to develop technology quickly in order to support market expansion over the projection period.

Restraining Factors

However, the high expense of treatment and competition from complementary therapies could slow down the market growth. Furthermore, there is a lack of professionals who are experts in such types of surgeries, and some of them individuals are not accepting new technology for fear of malfunction, which hampers the market expansion.

Market Segmentation

The United Kingdom cyberknife market share is classified into application and procedure.

• The oncology segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom cyberknife market is segmented by application into oncology, neurology, pain management, and pediatrics. Among these, the oncology segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by rising tumors, cancers, vascular malformations, and other applications. Also, cancer is becoming more common among diseases due to increased alcohol and tobacco use, sedentary lifestyles, and the increased adoption of bad diets are all factors that are contributing to the growth in the prevalence of cancer.

• The stereotactic radiosurgery segment held the largest market share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period.

The United Kingdom cyberknife market is segmented by procedure into stereotactic radiosurgery, stereotactic body radiation therapy, and fractionated stereotactic radiation therapy. Among these, the stereotactic radiosurgery segment held the largest market share in 2024 and is anticipated to grow at a substantial CAGR over the forecast period. This is because of the precision with which stereotactic radiosurgery targets tumors while causing the least amount of harm to adjacent healthy tissue, making it a popular option among physicians. Conversely, stereotactic body radiation therapy is becoming more popular because it works well for treating malignancies in different parts of the body, especially for patients whose tumors cannot be removed.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom cyberknife market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• The CyberKnife Centre
• Mount Vernon Cancer Centre
• The Harley Street Clinic
• Others

Recent Developments:

• In October 2020, The Royal Marsden in Sutton began treating patients with its latest CyberKnife system, a cutting-edge radiotherapy technology funded by The Royal Marsden Cancer Charity. This state-of-the-art machine delivers highly precise radiation therapy using robotic technology and real-time imaging, allowing for pinpoint accuracy while minimizing damage to healthy tissue.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom cyberknife market based on the below-mentioned segments:

United Kingdom Cyberknife Market, By Application

• Oncology
• Neurology
• Pain Management
• Pediatrics

United Kingdom Cyberknife Market, By Procedure

• Stereotactic Radiosurgery
• Stereotactic Body Radiation Therapy
• Fractionated Stereotactic Radiation Therapy